National Research Corp Stock Today
| NRC Stock | USD 17.41 0.16 0.93% |
Performance0 of 100
| Odds Of DistressLess than 10
|
National Research is trading at 17.41 as of the 17th of January 2025, a 0.93% increase since the beginning of the trading day. The stock's open price was 17.25. National Research has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 28th of January 2023 and ending today, the 17th of January 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 10th of October 1997 | Category Healthcare | Classification Health Care |
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska. The company has 23.48 M outstanding shares of which 324.94 K shares are now shorted by investors with about 2.78 days to cover. More on National Research Corp
Moving together with National Stock
Moving against National Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
National Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO, Director | Michael Hays | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Name | Nrc Ltd. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Oslo All Share, HNX, HNX MidSmall Cap, Health Care, Health Care Providers & Services, Health Information Services, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsNational Research can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand National Research's financial leverage. It provides some insight into what part of National Research's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
National Research Corp (NRC) is traded on NASDAQ Exchange in USA. It is located in 1245 Q Street, Lincoln, NE, United States, 68508 and employs 435 people. National Research is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 404.96 M. National Research Corp runs under Health Care Providers & Services sector within Health Care industry. The entity has 23.48 M outstanding shares of which 324.94 K shares are now shorted by investors with about 2.78 days to cover.
National Research Corp has about 32.97 M in cash with 38.11 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.33.
Check National Research Probability Of Bankruptcy
Ownership AllocationNational Research Corp maintains a total of 23.48 Million outstanding shares. Over half of National Research's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check National Ownership Details
National Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Wells Fargo & Co | 2024-09-30 | 171.8 K | |
| Hotchkis & Wiley Capital Management Llc | 2024-09-30 | 138.2 K | |
| Northwest & Ethical Investments L.p. | 2024-09-30 | 129.2 K | |
| Charles Schwab Investment Management Inc | 2024-09-30 | 123.7 K | |
| Bank Of America Corp | 2024-09-30 | 118.8 K | |
| Bank Of New York Mellon Corp | 2024-09-30 | 115.3 K | |
| Comerica Bank | 2024-09-30 | 99.8 K | |
| Envestnet Asset Management Inc | 2024-09-30 | 88.8 K | |
| Algert Global Llc | 2024-09-30 | 82.9 K | |
| Kayne Anderson Rudnick Investment Management Llc | 2024-09-30 | 3.1 M | |
| Blackrock Inc | 2024-09-30 | 1.2 M |
National Research Historical Income Statement
National Stock Against Markets
National Research Corporate Management
| CPA CPA | CFO, Fin | Profile | |
| Jennifer Baron | Chief Officer | Profile | |
| Gregory MS | Chief Officer | Profile | |
| Linda Stacy | Principal Officer | Profile | |
| Jona Raasch | Chief Officer | Profile | |
| Jon Boumstein | Chief Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Research Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Research. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Research listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.25) | Dividend Share 0.48 | Earnings Share 1.12 | Revenue Per Share | Quarterly Revenue Growth (0.06) |
The market value of National Research Corp is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Research's value that differs from its market value or its book value, called intrinsic value, which is National Research's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Research's market value can be influenced by many factors that don't directly affect National Research's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Research's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Research is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Research's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.